trending Market Intelligence /marketintelligence/en/news-insights/trending/_zkW2_dI6q0vFs6vIMCTuw2 content esgSubNav
In This List

Synergy Pharmaceuticals prices $125M common stock offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Synergy Pharmaceuticals prices $125M common stock offering

Synergy Pharmaceuticals Inc. priced a previously announced underwritten offering of shares at $6.15 apiece.

The company will issue 20,325,204 shares with closing expected by Feb. 6.

Cantor Fitzgerald & Co. and Canaccord Genuity Inc. are acting as joint book-running managers of the issue while H.C. Wainwright & Co. LLC is serving as co-manager.

Synergy plans to use amounts raised to fund the commercialization of Trulance while advancing the clinical development of Plecanatide, among other things.